Youngja Park obtained an M.S. and Ph.D in Pharmacology and Toxicology under Dr. James P. Kehrer at the University of Texas at Austin in 1990. She previously had worked as an Assistant Professor in the Department of Medicine and as the Assistant Director of the Clinical Biomarkers Laboratory at the Emory University School of Medicine since 2013. In Emory University, she developed LC-MS based metabolomics pipelines to identify novel biomarkers and the pathways associated with diseases. She published the number of metabolomics papers including Science and Journal of Allergy and Clinical Immunology. Currently she moved back to College of Pharmacy, Korea University where she has built metabolomics core facility after years of experience in research, evaluation and teaching both in hospital and education institutions. Her career goal is to identify the novel biomarkers and develop the sensors in early diagnoses of disease.